A Long-term, Safety, Tolerability, and Efficacy Study of Retigabine Immediate-release (IR) in Asian Adults With Partial Onset Seizures
Clinical trial NCT01777139 · COMPLETED
Trial details
- NCT number
- NCT01777139
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-11
- Primary completion
- 2016-12-14
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.